221 related articles for article (PubMed ID: 10984078)
1. Effect of growth hormone and pamidronate on bone blood flow, bone mineral and IGF-I levels in the rat.
Kapitola J; Zák J; Lacinová Z; Justová V
Physiol Res; 2000; 49 Suppl 1():S101-6. PubMed ID: 10984078
[TBL] [Abstract][Full Text] [Related]
2. Effect of pamidronate on bone blood flow in oophorectomized rats.
Kapitola J; Zák J
Physiol Res; 1998; 47(4):237-40. PubMed ID: 9803469
[TBL] [Abstract][Full Text] [Related]
3. [Effect of pamidronate on bone blood flow and serum levels of IGF-I in sham-operated and oophorectomized female rats].
Kapitola J; Zák J; Justová V; Lacinová Z
Sb Lek; 2002; 103(4):455-60. PubMed ID: 12688159
[TBL] [Abstract][Full Text] [Related]
4. Pamidronate prevents bone loss and decreased bone strength in adult female and male rats fed an isocaloric low-protein diet.
Mekraldi S; Toromanoff A; Rizzoli R; Ammann P
J Bone Miner Res; 2005 Aug; 20(8):1365-71. PubMed ID: 16007334
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment of growth hormone and the bisphosphonate pamidronate, versus treatment with GH alone, in GH-deficient adults: the effects on renal phosphate handling, bone turnover and bone mineral mass.
Valk NK; Erdtsieck RJ; Algra D; Lamberts SW; Pols HA
Clin Endocrinol (Oxf); 1995 Sep; 43(3):317-24. PubMed ID: 7586601
[TBL] [Abstract][Full Text] [Related]
6. [Role of IGF-I and NO on regulation of regional blood circulation in the bones of rats].
Kapitola J; Zák J; Lacinová Z; Justová V
Sb Lek; 2003; 104(1):103-9. PubMed ID: 14577141
[TBL] [Abstract][Full Text] [Related]
7. [Effect of calcitonin on regional blood flow in bones, serum levels of IGF-I and osteocalcin, density and weight of bone ash in oophorectomized rats].
Zák J; Kapitola J; Wallischová J
Sb Lek; 2003; 104(3):285-92. PubMed ID: 15224535
[TBL] [Abstract][Full Text] [Related]
8. [Effect of growth hormone on the structure of bone spongiosa in rats].
Zák J; Kapitola J; Povýsil C
Sb Lek; 1999; 100(2):109-14. PubMed ID: 11220160
[TBL] [Abstract][Full Text] [Related]
9. Further findings on the inhibitory effect of estradiol benzoate on the circulation and on 45Ca and 3H-proline incorporation in rat bones.
Kapitola J; Andrle J; Kubícková J
Exp Clin Endocrinol; 1992; 100(3):140-4. PubMed ID: 1305065
[TBL] [Abstract][Full Text] [Related]
10. Treatment of post-menopausal osteoporosis with a combination of growth hormone and pamidronate: a placebo controlled trial.
Erdtsieck RJ; Pols HA; Valk NK; van Ouwerkerk BM; Lamberts SW; Mulder P; Birkenhäger JC
Clin Endocrinol (Oxf); 1995 Nov; 43(5):557-65. PubMed ID: 8548940
[TBL] [Abstract][Full Text] [Related]
11. Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women.
Ghiron LJ; Thompson JL; Holloway L; Hintz RL; Butterfield GE; Hoffman AR; Marcus R
J Bone Miner Res; 1995 Dec; 10(12):1844-52. PubMed ID: 8619364
[TBL] [Abstract][Full Text] [Related]
12. Organ-specific effects and interactions of acute insulin-like growth factor I (IGF-I) and growth hormone (GH).
Pascual M; Larralde J; Martínez JA
Growth Dev Aging; 1995; 59(4):181-91. PubMed ID: 8770610
[TBL] [Abstract][Full Text] [Related]
13. Effect of growth hormone on bone: bone mineral density, trabecular bone volume, and alkaline phosphatase improve or are restored in the dwarf rat treated with growth hormone.
Wright NM; Renault J; Hollis B; Bell NH; Key LL
J Bone Miner Res; 1995 Jan; 10(1):127-31. PubMed ID: 7747619
[TBL] [Abstract][Full Text] [Related]
14. Administration of growth hormone in selectively protein-deprived rats decreases BMD and bone strength.
Ammann P; Brennan TC; Mekraldi S; Aubert ML; Rizzoli R
Bone; 2010 Jun; 46(6):1574-81. PubMed ID: 20178866
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of bone resorption by pamidronate cannot restore normal gain in cortical bone mass and strength in tail-suspended rapidly growing rats.
Kodama Y; Nakayama K; Fuse H; Fukumoto S; Kawahara H; Takahashi H; Kurokawa T; Sekiguchi C; Nakamura T; Matsumoto T
J Bone Miner Res; 1997 Jul; 12(7):1058-67. PubMed ID: 9200005
[TBL] [Abstract][Full Text] [Related]
16. Short-term effects of growth hormone and insulin-like growth factor I on cancellous bone in rhesus macaque monkeys.
Sass DA; Jerome CP; Bowman AR; Bennett-Cain A; Ginn TA; LeRoith D; Epstein S
J Clin Endocrinol Metab; 1997 Apr; 82(4):1202-9. PubMed ID: 9100597
[TBL] [Abstract][Full Text] [Related]
17. The molecular response of bone to growth hormone during skeletal unloading: regional differences.
Bikle DD; Harris J; Halloran BP; Currier PA; Tanner S; Morey-Holton E
Endocrinology; 1995 May; 136(5):2099-109. PubMed ID: 7720659
[TBL] [Abstract][Full Text] [Related]
18. Different effects of oestradiol benzoate and norethisterone on the blood flow and mineral content in rat bones.
Kapitola J; Schreiber V; Andrle J; Kubícková J
Physiol Res; 1992; 41(5):393-8. PubMed ID: 1286112
[TBL] [Abstract][Full Text] [Related]
19. Calcitropic hormones and IGF-I are influenced by dietary protein.
Dubois-Ferrière V; Brennan TC; Dayer R; Rizzoli R; Ammann P
Endocrinology; 2011 May; 152(5):1839-47. PubMed ID: 21343254
[TBL] [Abstract][Full Text] [Related]
20. Olpadronate prevents the bone loss induced by cyclosporine in the rat.
Zeni SN; Gregorio S; Gomez AC; Somoza J; Mautalen C
Calcif Tissue Int; 2002 Jan; 70(1):48-53. PubMed ID: 11907707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
